Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer

BACKGROUND: Plasma tumour DNA (ptDNA) levels on treatment are associated with response in a variety of cancers. However, the role of ptDNA in prostate cancer monitoring remains largely unexplored. Here we characterised on-treatment ptDNA dynamics and evaluated its potential for early assessment of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Conteduca, Vincenza, Wetterskog, Daniel, Scarpi, Emanuela, Romanel, Alessandro, Gurioli, Giorgia, Jayaram, Anuradha, Lolli, Cristian, Tandefelt, Delila Gasi, Schepisi, Giuseppe, Casadei, Chiara, Wingate, Anna, Matteucci, Federica, Paganelli, Giovanni, Gonzalez-Billalabeitia, Enrique, Demichelis, Francesca, De Giorgi, Ugo, Attard, Gerhardt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492429/
https://www.ncbi.nlm.nih.gov/pubmed/32669676
http://dx.doi.org/10.1038/s41416-020-0969-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492429/
https://www.ncbi.nlm.nih.gov/pubmed/32669676
http://dx.doi.org/10.1038/s41416-020-0969-5

Ejemplares similares